首頁 > 市場調查報告書 > 醫療設備

市場調查報告書

商品編碼

1918197

精子庫市場－2026-2031年預測

Sperm Bank Market - Forecast from 2026 to 2031

出版日期: 2026年01月16日 | 出版商:

Knowledge Sourcing Intelligence | 英文 142 Pages | 商品交期: 最快1-2個工作天內

價格

簡介目錄

預計精子庫市場將從 2025 年的 48.02 億美元成長到 2031 年的 62.33 億美元，複合年成長率為 4.44%。

精子庫市場是輔助生殖技術（ART）和生殖醫學產業內的一個專業領域，專注於捐精的取得、冷凍保存、品質保證和分發。這些營業單位是生育診所和直接消費者的重要精子供應來源，使面臨男性不孕症的個人和夫婦、單身女性以及女同性戀伴侶能夠建立家庭。

核心服務職能與臨床角色

精子庫作為受嚴格監管的生物樣本庫和服務供應商運作。其核心業務包括嚴格的捐精者招募和篩檢（包括醫學、遺傳和心理評估）、精液處理和冷凍保存、全面的傳染病檢查以及安全的長期儲存。精子庫提供詳細的捐精者資訊，並協助將檢體匹配並運送至獲得許可的醫療機構或直接運送至消費者，用於宮腔內人工授精（IUI）和體外受精（IVF）等手術。精子庫的功能是滿足第三方輔助生殖的基本生物學需求，並確保安全、可靠且符合倫理規範地供應生殖細胞。

主要市場成長要素

市場擴張的根本促進因素是全球不孕症發病率的上升以及人們對男性因素影響的認知不斷提高。環境、生活方式和肥胖等因素導致的精子參數下降，使得需要捐精的患者群體不斷擴大。同時，晚婚趨勢（可能影響男性和女性的生育能力）也進一步推動了不孕症治療服務（包括捐精）的需求。

重要的社會人口結構變化正在重塑和擴大消費群。社會對多元化家庭結構的接受度不斷提高，法律授權，包括選擇單身的女性和女同性戀伴侶，這催生了一個龐大而獨特的需求群體，他們幾乎完全依賴捐精來實現受孕。這種人口結構的變化正在將市場拓展到傳統上以面臨嚴重男性不孕症的異性戀夫婦為主導的領域之外。

肥胖症的增加是一個特定的生理因素，因為它與男性荷爾蒙失衡和精液品質差有關，這間接地支持了市場需求，擴大了尋求不孕症檢測和捐精解決方案的人群範圍。

相關診斷和輔助生殖技術的進步也推動了市場的發展。精液分析技術的改進以及臨床上對男性不孕症評估的日益重視，導致需要使用捐精的病例數量不斷增加。此外，體外受精（IVF）和人工授精（IUI）等輔助生殖技術（ART）的廣泛應用和成功，為捐精的利用提供了一條重要的臨床途徑，從而產生了協同效應。

一些地區的政府支持政策（儘管各不相同）和不斷完善的法規結構正在促進市場准入和合法性。政府資助生育治療、建立公共配子庫以及製定關於捐精和子女權利的明確法律準則，可以減少障礙，並鼓勵在受監管的體系內推廣使用。

主要服務業和消費者偏好

市場按服務類型細分，精液分析和儲存服務是診斷和生育力保存的核心產品，但用於治療目的的捐精分發構成了主要的收入來源。

消費者的偏好往往需要在成本和複雜性之間做出權衡。與體外受精（IVF）相比，使用捐精進行人工授精（IUI）由於成本相對較低且創傷性小，仍然是一種重要的促排卵方法，這推動了嘗試這一一線治療方案的個人和夫婦對捐精的需求。然而，體外受精的高成功率，尤其是在年齡較大的求子者和存在其他不孕因素的患者中，也使得對更複雜的治療週期的需求保持強勁。

區域背景和監管成熟度

北美是一個成熟且重要的市場，其特點是擁有完善的商業和非營利精子庫網路、對輔助生殖技術（ART）服務的高度認知和利用率，以及相對穩定的法規環境。眾多全球性公司的存在和先進的臨床基礎設施鞏固了其主導地位。

歐洲是一個重要且成熟的市場，擁有悠久的公共和私人精子庫體系、完善的捐精者監管規定，並且在許多國家消費者都能便捷地獲取精子。成熟的營運機構和細緻的捐精者資訊評估是該地區的優勢所在。

亞太地區被公認為高成長市場，其成長動力主要來自大規模的人口基數、不斷上升的不孕不育率、生殖健康服務醫療旅遊的興起以及人們對捐精受孕文化態度的逐漸轉變。醫療保健體系的完善和國際精子庫的進入正在加速市場發展。

競爭格局與策略演變

競爭格局包括擁有龐大捐精者名錄和全球分銷網路的國際大規模精子庫，以及區域性專業精子庫和診所附屬精子庫。競爭的重點在於捐精者的多樣性和資料深度、嚴格的品質和安全標準、客戶服務（包括用於選擇捐精者的線上平台）以及可靠的運輸物流和地理覆蓋。

策略性措施著重於擴大捐贈者招募範圍，以滿足不同種族和表現型的需求；改進數位化介面，打造流暢的客戶體驗；以及應對複雜的國際進出口法規，開拓新市場。此外，投資基因篩檢技術以確保產品質量，以及研究冷凍保存樣本的長期儲存潛力，也是重點關注領域。

未來市場趨勢

精子庫市場的未來發展趨勢是朝著更個人化、基因透明化和全球可及性的方向發展。消費者需求正在轉向更充分地揭露捐贈者的基因和健康資訊。將先進的基因篩檢（例如，擴展的攜帶者篩檢）納入捐贈者評估流程將日益成為標準做法。

關於捐精者匿名、後代資訊揭露權和補償模式的倫理辯論和不斷變化的法規將持續影響市場格局。產業相關人員的成功取決於能否堅持最高的醫療和倫理標準，適應多元化的法律環境，並滿足日益成長且更加多元化的全球客戶群不斷變化的期望。隨著計劃生育和家庭結構多元化的社會趨勢持續發展，精子庫市場預計將穩定成長，並成為現代生殖健康生態系統的重要組成部分。

本報告的主要優勢：

深入分析：提供對主要和新興地區的深入市場洞察，重點關注客戶群、政府政策和社會經濟因素、消費者偏好、行業垂直領域和其他細分市場。
競爭格局：了解全球主要參與者的策略舉措，並了解透過正確的策略進入市場的機會。
市場促進因素與未來趨勢：探討影響市場的動態因素和關鍵趨勢及其對未來市場發展的影響。
可操作的建議：利用這些見解，在動態環境中製定策略決策，發展新的業務流和收入來源。
受眾廣泛：適用於Start-Ups、研究機構、顧問公司、中小企業和大型企業，且經濟實惠。

它是用來做什麼的？

產業與市場分析、機會評估、產品需求預測、打入市場策略、地理擴張、資本投資決策、法規結構及影響、新產品開發、競爭情報

報告範圍：

2022年至2024年的歷史數據和2025年至2031年的預測數據
成長機會、挑戰、供應鏈前景、法規結構與趨勢分析
競爭定位、策略和市場佔有率分析
按業務板塊和地區（包括國家）分類的收入和預測評估
公司概況（策略、產品、財務資訊、關鍵發展等）

介紹
北美洲
- 美國
- 加拿大
- 墨西哥
南美洲
- 巴西
- 阿根廷
- 其他
歐洲
- 英國
- 德國
- 法國
- 西班牙
- 其他
中東和非洲
- 沙烏地阿拉伯
- 阿拉伯聯合大公國
- 以色列
- 其他
亞太地區
- 日本
- 中國
- 印度
- 韓國
- 印尼
- 泰國
- 其他

第9章競爭格局與分析

主要企業和策略分析
市佔率分析
合併、收購、協議和合作
供應商競爭力矩陣

第10章：公司簡介

Xytex
Fairfax Cryobank
California Cryobank
Cryos International
Seattle Sperm Bank
Johns Hopkins Medicine
Apollo Fertility
Indira IVF
Birla Fertility and IVF

簡介目錄

Product Code: KSI061616026

Sperm Bank Market is projected to grow at a 4.44% CAGR, reaching USD 6.233 billion in 2031 from USD 4.802 billion in 2025.

The sperm bank market is a specialized segment within the broader assisted reproductive technology (ART) and reproductive health industry, focused on the procurement, cryopreservation, quality assurance, and distribution of donor sperm. These entities function as critical suppliers to fertility clinics and direct consumers, enabling family building for individuals and couples facing male factor infertility, single women, and same-sex female couples.

Core Service Function and Clinical Role

Sperm banks operate as highly regulated biorepositories and service providers. Their core activities involve rigorous donor recruitment and screening (including medical, genetic, and psychological evaluations), semen processing and cryopreservation, extensive infectious disease testing, and secure long-term storage. They provide detailed donor profiles and facilitate the matching and shipment of specimens to licensed healthcare providers or directly to consumers for use in procedures such as intrauterine insemination (IUI) or in-vitro fertilization (IVF). Their role is to ensure a safe, reliable, and ethically managed supply of gametes, addressing a fundamental biological need in third-party reproduction.

Primary Market Growth Drivers

Market expansion is fundamentally driven by the rising global prevalence of infertility, with increasing acknowledgment of male factor contributors. Declining sperm parameters linked to environmental, lifestyle, and obesity-related factors are expanding the patient population requiring donor gametes. Concurrently, the trend toward delayed parenthood, which can impact both male and female fertility, further elevates the utilization of fertility services, including those involving donor sperm.

Significant sociodemographic shifts are reshaping and broadening the consumer base. The growing social acceptance and legal recognition of diverse family structures-including single women by choice and lesbian couples-has created substantial, dedicated demand segments that rely almost exclusively on donor sperm to achieve pregnancy. This demographic evolution has moved the market beyond its traditional base of heterosexual couples facing severe male infertility.

The increasing prevalence of obesity represents a specific physiological driver, as it is associated with hormonal imbalances and reduced semen quality in men. This contributes to the pool of individuals seeking fertility evaluation and potentially donor solutions, thereby indirectly supporting market demand.

Advancements in related diagnostic and reproductive technologies also stimulate the market. Improved semen analysis techniques and a greater clinical focus on male fertility assessment lead to more diagnoses of conditions necessitating donor sperm. Furthermore, the growth and success of ART procedures like IVF and IUI provide the essential clinical pathways through which donor sperm is utilized, creating a synergistic relationship.

Supportive, though varied, government initiatives and evolving regulatory frameworks in some regions are facilitating market access and legitimacy. Public funding for fertility treatments, the establishment of public gamete banks, and clear legal guidelines for donor conception and offspring rights can reduce barriers and encourage utilization within regulated systems.

Key Service Segments and Consumer Preferences

The market is segmented by service type, with semen analysis and storage services representing a core offering for diagnostic and fertility preservation purposes. However, the distribution of donor sperm for therapeutic use constitutes the primary revenue stream.

Consumer preference often involves a trade-off between cost and complexity. Donor insemination (IUI) remains a significant entry point due to its relatively lower cost and less invasive nature compared to IVF, driving demand for donor sperm from individuals and couples attempting this first-line treatment. However, the higher success rates of IVF, particularly for older recipients or those with additional fertility factors, also sustain strong demand within more complex treatment cycles.

Geographic Landscape and Regulatory Maturity

North America represents a mature and dominant market, characterized by a well-established network of commercial and non-profit banks, high awareness and utilization of ART services, and a relatively stable regulatory environment. The presence of major global market players and advanced clinical infrastructure consolidates its leadership.

Europe is a significant and sophisticated market, with a strong tradition of both public and private banking systems, comprehensive donor regulation, and high levels of consumer access in many countries. The region benefits from established players and a culture of detailed donor profiling.

The Asia-Pacific region is identified as a high-growth market, fueled by large populations, rising infertility rates, increasing medical tourism for reproductive services, and gradual shifts in cultural attitudes toward donor conception. Improving healthcare systems and the entry of international banks are accelerating market development.

Competitive Landscape and Strategic Evolution

The competitive environment includes large international cryobanks with extensive donor catalogues and global distribution networks, regional specialists, and clinic-affiliated banks. Competition centers on donor diversity and profile depth, rigorous quality and safety standards, customer service (including online platforms for donor selection), and geographic reach through reliable shipping logistics.

Strategic initiatives focus on expanding donor recruitment to meet diverse ethnic and phenotypic demands, enhancing digital interfaces for a seamless client experience, and navigating complex international import/export regulations to access new markets. Investments in genetic screening technologies and long-term viability studies of cryopreserved samples are also key areas of focus to ensure product quality.

Future Market Trajectory

The future trajectory of the sperm bank market is oriented toward greater personalization, genetic transparency, and global accessibility. Consumer demand is shifting toward more extensive donor genetic and health information. The integration of advanced genetic screening (e.g., expanded carrier screening) into donor evaluation will become increasingly standard.

The market will continue to be shaped by ethical debates and regulatory evolution concerning donor anonymity, offspring rights to information, and compensation models. Success for industry participants will depend on maintaining the highest standards of medical and ethical practice, adapting to diverse legal landscapes, and meeting the evolving expectations of a more informed and diverse global clientele. As societal trends toward planned parenthood and diverse family formation persist, the sperm bank market is poised for steady growth, serving as an essential component in the ecosystem of modern reproductive medicine.

Key Benefits of this Report:

Insightful Analysis: Gain detailed market insights covering major as well as emerging geographical regions, focusing on customer segments, government policies and socio-economic factors, consumer preferences, industry verticals, and other sub-segments.
Competitive Landscape: Understand the strategic maneuvers employed by key players globally to understand possible market penetration with the correct strategy.
Market Drivers & Future Trends: Explore the dynamic factors and pivotal market trends and how they will shape future market developments.
Actionable Recommendations: Utilize the insights to exercise strategic decisions to uncover new business streams and revenues in a dynamic environment.
Caters to a Wide Audience: Beneficial and cost-effective for startups, research institutions, consultants, SMEs, and large enterprises.

What do businesses use our reports for?

Industry and Market Insights, Opportunity Assessment, Product Demand Forecasting, Market Entry Strategy, Geographical Expansion, Capital Investment Decisions, Regulatory Framework & Implications, New Product Development, Competitive Intelligence

Report Coverage:

Historical data from 2022 to 2024 & forecast data from 2025 to 2031
Growth Opportunities, Challenges, Supply Chain Outlook, Regulatory Framework, and Trend Analysis
Competitive Positioning, Strategies, and Market Share Analysis
Revenue Growth and Forecast Assessment of segments and regions including countries
Company Profiling (Strategies, Products, Financial Information, and Key Developments among others.)

Sperm Bank Market Segmentation:

By Donor Type
Known Donor
Anonymous Donor
By Service
Sperm Storage
Semen Analysis
Genetic Consultation
By Fertilization Techniques
Donor Insemination
In Vitro Insemination
By Geography
North America
United States
Canada
Mexico
South America
Brazil
Argentina
Others
Europe
United Kingdom
Germany
France
Spain
Others
Middle East and Africa
Saudi Arabia
UAE
Israel
Others
Asia Pacific
Japan
China
India
South Korea
Indonesia
Thailand
Others

1. INTRODUCTION

1.1. Market Overview
1.2. Market Definition
1.3. Scope of the Study
1.4. Market Segmentation
1.5. Currency
1.6. Assumptions
1.7. Base, and Forecast Years Timeline

2. RESEARCH METHODOLOGY

2.1. Research Data
2.2. Assumptions

3. EXECUTIVE SUMMARY

3.1. Research Highlights

4. MARKET DYNAMICS

4.1. Market Drivers
4.2. Market Restraints
4.3. Porter's Five Force Analysis
- 4.3.1. Bargaining Power of Suppliers
- 4.3.2. Bargaining Power of Buyers
- 4.3.3. Threat of New Entrants
- 4.3.4. Threat of Substitutes
- 4.3.5. Competitive Rivalry in the Industry
4.4. Industry Value Chain Analysis

5. SPERM BANK MARKET, BY DONOR TYPE

5.1. Introduction
5.2. Known Donor
5.3. Anonymous Donor

6. SPERM BANK MARKET, BY SERVICE

6.1. Introduction
6.2. Sperm Storage
6.3. Semen Analysis
6.4. Genetic Consultation

7. SPERM BANK MARKET, BY FERTILIZATION TECHNIQUES

7.1. Introduction
7.2. Donor Insemination
7.3. In Vitro Insemination

8. SPERM BANK MARKET, BY GEOGRAPHY

8.1. Introduction
8.2. North America
- 8.2.1. United States
- 8.2.2. Canada
- 8.2.3. Mexico
8.3. South America
- 8.3.1. Brazil
- 8.3.2. Argentina
- 8.3.3. Others
8.4. Europe
- 8.4.1. United Kingdom
- 8.4.2. Germany
- 8.4.3. France
- 8.4.4. Spain
- 8.4.5. Others
8.5. The Middle East and Africa
- 8.5.1. Saudi Arabia
- 8.5.2. UAE
- 8.5.3. Israel
- 8.5.4. Others
8.6. Asia Pacific
- 8.6.1. Japan
- 8.6.2. China
- 8.6.3. India
- 8.6.4. South Korea
- 8.6.5. Indonesia
- 8.6.6. Thailand
- 8.6.7. Others